白细胞吸附疗法在炎症性肠病中的应用进展

被引:13
作者
周雪婷 [1 ]
李俊 [1 ]
毛蕾 [1 ]
刘金武 [1 ]
王祥 [2 ]
机构
[1] 兰州大学第二临床医学院
[2] 兰州大学第二临床医学院兰州大学第二医院消化科
关键词
炎症性肠病; 溃疡性结肠炎; 克罗恩病; 白细胞吸附疗法; LCAP; GMA;
D O I
暂无
中图分类号
R574 [肠疾病];
学科分类号
100201 [内科学];
摘要
白细胞吸附疗法是一种新兴的治疗炎症性肠病(inflammatory bowel disease,IBD)的非药物疗法,在活动性IBD、激素依赖性或难治性溃疡性结肠炎(ulcerative colitis,UC)、IBD合并症及不能耐受药物治疗的患者中均显示出一定疗效,其作用机制不仅限于白细胞的去除,还涉及淋巴、单核细胞及特殊表型细胞分布的改变,以及一些细胞因子、免疫复合物的变化。作为一种新型的治疗方法,目前已发现一些可以预测其疗效的指标用以指导其临床应用,现就治疗IBD的可能机制及临床应用中的若干问题作一概述。
引用
收藏
页码:99 / 103
页数:5
相关论文
共 19 条
[1]
炎症性肠病免疫发病机制的研究进展 [J].
张金玲 ;
杜光 ;
李娟 .
胃肠病学和肝病学杂志, 2019, 28 (09) :1051-1055
[2]
免疫抑制治疗对HBsAg阳性炎症性肠病患者HBV再活动的影响 [J].
舒慧君 ;
李骥 ;
杨红 ;
钱家鸣 .
胃肠病学和肝病学杂志, 2016, 25 (10) :1127-1131
[3]
Promises and paradoxes of regulatory T cells in inflammatory bowel disease [J].
Lord, James D. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (40) :11236-11245
[4]
Treating inflammatory bowel disease by adsorptive leucocytapheresis: A desire to treat without drugs [J].
Saniabadi, Abbi R. ;
Tanaka, Tomotaka ;
Ohmori, Toshihide ;
Sawada, Koji ;
Yamamoto, Takayuki ;
Hanai, Hiroyuki .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (29) :9699-9715
[5]
Safety and efficacy of leukocytapheresis in elderly patients with ulcerative colitis: The impact in steroid-free elderly patients [J].
Komoto, Shunsuke ;
Matsuoka, Katsuyoshi ;
Kobayashi, Taku ;
Yokoyama, Yoko ;
Suzuki, Yasuo ;
Hibi, Toshifumi ;
Miura, Soichiro ;
Hokari, Ryota .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (08) :1485-1491
[6]
Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis [J].
Dignass, Axel ;
Akbar, Ayesha ;
Baumgart, Daniel C. ;
Bommelaer, Gilles ;
Bouguen, Guillaume ;
Cadiot, Guillaume ;
Gillessen, Anton ;
Grimaud, Jean-Charles ;
Hart, Ailsa ;
Hoque, Syed ;
Makins, Richard ;
Michiels, Christophe ;
Moreau, Jacques ;
Premchand, Purushothaman ;
Ramlow, Wolfgang ;
Schanz, Stefan ;
Subramanian, Sreedhar ;
von Tirpitz, Christian ;
Bonaz, Bruno .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (04) :442-448
[7]
Inflammatory bowel disease patients experiencing a loss of response to infliximab regain long-term response after undergoing granulocyte/monocyte apheresis: A case series.[J].Yoko Yokoyama;Koji Kamikozuru;Kenji Watanabe;Shiro Nakamura.Cytokine.2018,
[8]
Granulocyte and Monocyte Apheresis for Induction of Remission in Children With New Onset Inflammatory Bowel Colitis.[J].Helena Rolandsdotter;Michael Eberhardson;Ulrika L. Fagerberg;Yigael Finkel.Journal of Pediatric Gastroenterology and Nutriti.2017,
[9]
Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease [J].
Saez-Gonzalez, Esteban ;
Moret, Ines ;
Alvarez-Sotomayor, Diego ;
Carolina Diaz-Jaime, Francia ;
Cerrillo, Elena ;
Iborra, Marisa ;
Nos, Pilar ;
Beltran, Belen .
DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (06) :1417-1425
[10]
Serum Cytokine Profiling of Leukocytapheresis in Pediatric Ulcerative Colitis [J].
Kashiwagi, Yasuyo ;
Go, Soken ;
Kinjo, Naoko ;
Nishimata, Shigeo ;
Kawashima, Hisashi .
THERAPEUTIC APHERESIS AND DIALYSIS, 2015, 19 (04) :413-415